Literature DB >> 1201399

Proceedings: Effects of prostaglandins E1, E2 and D2 on platelet aggregation: variation with animal species and ionized calcium concentration.

J L Gordon, D E MacIntyre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1201399      PMCID: PMC1666819     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  Prostaglandins as haemostatic agents.

Authors:  R L Fenichel; D D Stokes; H E Alburn
Journal:  Nature       Date:  1975-02-13       Impact factor: 49.962

2.  Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium.

Authors:  R L Vigdahl; N R Marquis; P A Tavormina
Journal:  Biochem Biophys Res Commun       Date:  1969-10-22       Impact factor: 3.575

3.  Effects of prostaglandin E2 on human platelet adenyl cyclase and aggregation.

Authors:  J J Bruno; L A Taylor; M J Droller
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

4.  Prostaglandin D2 inhibits the aggregation of human platelets.

Authors:  J B Smith; M J Silver; C M Ingerman; J J Kocsis
Journal:  Thromb Res       Date:  1974-09       Impact factor: 3.944

5.  Isolation of a chemical trigger for thrombosis.

Authors:  A L Willis
Journal:  Prostaglandins       Date:  1974-01-10

6.  Proceedings: Inhibition of collagen-induced platelet aggregation by aspirin.

Authors:  J L Gordon; D E Macintyre
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

7.  A simple fluorimetric microassay for adenine compounds in platelets and plasma and its application to studies on the platelet release reaction.

Authors:  J L Gordon; A H Drummond
Journal:  Biochem J       Date:  1974-02       Impact factor: 3.857

  7 in total
  1 in total

1.  Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock.

Authors:  P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.